nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.187	1	CbGbCtD
Mirtazapine—Asphyxia—Riluzole—amyotrophic lateral sclerosis	0.022	0.0418	CcSEcCtD
Mirtazapine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.015	0.0752	CbGeAlD
Mirtazapine—Psychotic depression—Riluzole—amyotrophic lateral sclerosis	0.0132	0.025	CcSEcCtD
Mirtazapine—Hypoaesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0106	0.0201	CcSEcCtD
Mirtazapine—Major depression—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0195	CcSEcCtD
Mirtazapine—Salivary gland enlargement—Riluzole—amyotrophic lateral sclerosis	0.00995	0.0189	CcSEcCtD
Mirtazapine—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.00971	0.0485	CbGeAlD
Mirtazapine—HRH3—hindbrain—amyotrophic lateral sclerosis	0.00778	0.0389	CbGeAlD
Mirtazapine—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.00741	0.0141	CcSEcCtD
Mirtazapine—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00698	0.0133	CcSEcCtD
Mirtazapine—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00673	0.0128	CcSEcCtD
Mirtazapine—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00649	0.0123	CcSEcCtD
Mirtazapine—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.00628	0.0314	CbGeAlD
Mirtazapine—HTR7—pons—amyotrophic lateral sclerosis	0.00621	0.031	CbGeAlD
Mirtazapine—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.00589	0.0112	CcSEcCtD
Mirtazapine—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.00571	0.0109	CcSEcCtD
Mirtazapine—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00571	0.0109	CcSEcCtD
Mirtazapine—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.00555	0.0105	CcSEcCtD
Mirtazapine—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00555	0.0105	CcSEcCtD
Mirtazapine—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00525	0.00998	CcSEcCtD
Mirtazapine—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00499	0.00947	CcSEcCtD
Mirtazapine—HTR3A—nerve—amyotrophic lateral sclerosis	0.00498	0.0249	CbGeAlD
Mirtazapine—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00487	0.00924	CcSEcCtD
Mirtazapine—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00487	0.00924	CcSEcCtD
Mirtazapine—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00481	0.00913	CcSEcCtD
Mirtazapine—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00464	0.00882	CcSEcCtD
Mirtazapine—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.00459	0.00872	CcSEcCtD
Mirtazapine—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00459	0.00872	CcSEcCtD
Mirtazapine—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00454	0.00862	CcSEcCtD
Mirtazapine—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00853	CcSEcCtD
Mirtazapine—HRH3—brainstem—amyotrophic lateral sclerosis	0.00446	0.0223	CbGeAlD
Mirtazapine—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00439	0.00835	CcSEcCtD
Mirtazapine—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00826	CcSEcCtD
Mirtazapine—Embolism—Riluzole—amyotrophic lateral sclerosis	0.0043	0.00817	CcSEcCtD
Mirtazapine—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00801	CcSEcCtD
Mirtazapine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.00414	0.0207	CbGeAlD
Mirtazapine—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00413	0.0206	CbGeAlD
Mirtazapine—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00777	CcSEcCtD
Mirtazapine—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00405	0.0077	CcSEcCtD
Mirtazapine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00405	0.0077	CcSEcCtD
Mirtazapine—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00405	0.0077	CcSEcCtD
Mirtazapine—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00394	0.00748	CcSEcCtD
Mirtazapine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00392	0.0196	CbGeAlD
Mirtazapine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0039	0.00741	CcSEcCtD
Mirtazapine—HTR2A—pons—amyotrophic lateral sclerosis	0.00387	0.0193	CbGeAlD
Mirtazapine—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00734	CcSEcCtD
Mirtazapine—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00734	CcSEcCtD
Mirtazapine—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00728	CcSEcCtD
Mirtazapine—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00383	0.00728	CcSEcCtD
Mirtazapine—Mania—Riluzole—amyotrophic lateral sclerosis	0.0038	0.00721	CcSEcCtD
Mirtazapine—Stupor—Riluzole—amyotrophic lateral sclerosis	0.0037	0.00703	CcSEcCtD
Mirtazapine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00697	CcSEcCtD
Mirtazapine—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00697	CcSEcCtD
Mirtazapine—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00358	0.00679	CcSEcCtD
Mirtazapine—Skin ulcer—Riluzole—amyotrophic lateral sclerosis	0.00355	0.00674	CcSEcCtD
Mirtazapine—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00343	0.00653	CcSEcCtD
Mirtazapine—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00648	CcSEcCtD
Mirtazapine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00336	0.00638	CcSEcCtD
Mirtazapine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00334	0.0167	CbGeAlD
Mirtazapine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.0033	0.0165	CbGeAlD
Mirtazapine—HTR7—nerve—amyotrophic lateral sclerosis	0.00322	0.0161	CbGeAlD
Mirtazapine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00321	0.0061	CcSEcCtD
Mirtazapine—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00316	0.00601	CcSEcCtD
Mirtazapine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00597	CcSEcCtD
Mirtazapine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.0031	0.0155	CbGeAlD
Mirtazapine—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00585	CcSEcCtD
Mirtazapine—Bone disorder—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00581	CcSEcCtD
Mirtazapine—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00581	CcSEcCtD
Mirtazapine—DRD2—nerve—amyotrophic lateral sclerosis	0.00304	0.0152	CbGeAlD
Mirtazapine—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00577	CcSEcCtD
Mirtazapine—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00577	CcSEcCtD
Mirtazapine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00303	0.0151	CbGeAlD
Mirtazapine—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00573	CcSEcCtD
Mirtazapine—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00573	CcSEcCtD
Mirtazapine—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.003	0.00569	CcSEcCtD
Mirtazapine—Gout—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00562	CcSEcCtD
Mirtazapine—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00555	CcSEcCtD
Mirtazapine—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00555	CcSEcCtD
Mirtazapine—Ulcer—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00555	CcSEcCtD
Mirtazapine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00284	0.0142	CbGeAlD
Mirtazapine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00283	0.0142	CbGeAlD
Mirtazapine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00534	CcSEcCtD
Mirtazapine—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00279	0.00531	CcSEcCtD
Mirtazapine—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00525	CcSEcCtD
Mirtazapine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00276	0.00525	CcSEcCtD
Mirtazapine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00518	CcSEcCtD
Mirtazapine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00507	CcSEcCtD
Mirtazapine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00267	0.00507	CcSEcCtD
Mirtazapine—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00264	0.00501	CcSEcCtD
Mirtazapine—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00498	CcSEcCtD
Mirtazapine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00259	0.00493	CcSEcCtD
Mirtazapine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00258	0.0129	CbGeAlD
Mirtazapine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00252	0.0126	CbGeAlD
Mirtazapine—Coma—Riluzole—amyotrophic lateral sclerosis	0.00252	0.00479	CcSEcCtD
Mirtazapine—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00246	0.00467	CcSEcCtD
Mirtazapine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00242	0.0046	CcSEcCtD
Mirtazapine—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00241	0.0121	CbGeAlD
Mirtazapine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00455	CcSEcCtD
Mirtazapine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00237	0.00451	CcSEcCtD
Mirtazapine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00446	CcSEcCtD
Mirtazapine—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00235	0.00446	CcSEcCtD
Mirtazapine—HRH3—nervous system—amyotrophic lateral sclerosis	0.00234	0.0117	CbGeAlD
Mirtazapine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00233	0.0116	CbGeAlD
Mirtazapine—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00442	CcSEcCtD
Mirtazapine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.0023	0.00438	CcSEcCtD
Mirtazapine—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00229	0.00436	CcSEcCtD
Mirtazapine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00228	0.0114	CbGeAlD
Mirtazapine—HRH3—central nervous system—amyotrophic lateral sclerosis	0.00225	0.0112	CbGeAlD
Mirtazapine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00426	CcSEcCtD
Mirtazapine—HRH3—cerebellum—amyotrophic lateral sclerosis	0.0022	0.011	CbGeAlD
Mirtazapine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00216	0.00411	CcSEcCtD
Mirtazapine—HTR3A—brainstem—amyotrophic lateral sclerosis	0.00214	0.0107	CbGeAlD
Mirtazapine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00405	CcSEcCtD
Mirtazapine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00405	CcSEcCtD
Mirtazapine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00404	CcSEcCtD
Mirtazapine—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00211	0.004	CcSEcCtD
Mirtazapine—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00206	0.00392	CcSEcCtD
Mirtazapine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00382	CcSEcCtD
Mirtazapine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00201	0.01	CbGeAlD
Mirtazapine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.002	0.00381	CcSEcCtD
Mirtazapine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.002	0.00381	CcSEcCtD
Mirtazapine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00378	CcSEcCtD
Mirtazapine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00375	CcSEcCtD
Mirtazapine—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00197	0.00375	CcSEcCtD
Mirtazapine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00372	CcSEcCtD
Mirtazapine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00368	CcSEcCtD
Mirtazapine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00191	0.00362	CcSEcCtD
Mirtazapine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00361	CcSEcCtD
Mirtazapine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00358	CcSEcCtD
Mirtazapine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00354	CcSEcCtD
Mirtazapine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00352	CcSEcCtD
Mirtazapine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00183	0.00348	CcSEcCtD
Mirtazapine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00343	CcSEcCtD
Mirtazapine—HRH3—brain—amyotrophic lateral sclerosis	0.00178	0.00892	CbGeAlD
Mirtazapine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00178	0.00888	CbGeAlD
Mirtazapine—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00337	CcSEcCtD
Mirtazapine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00336	CcSEcCtD
Mirtazapine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00336	CcSEcCtD
Mirtazapine—DRD4—brain—amyotrophic lateral sclerosis	0.00176	0.00879	CbGeAlD
Mirtazapine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00331	CcSEcCtD
Mirtazapine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00329	CcSEcCtD
Mirtazapine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00329	CcSEcCtD
Mirtazapine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00172	0.00859	CbGeAlD
Mirtazapine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00323	CcSEcCtD
Mirtazapine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00321	CcSEcCtD
Mirtazapine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00317	CcSEcCtD
Mirtazapine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00164	0.00313	CcSEcCtD
Mirtazapine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00163	0.00814	CbGeAlD
Mirtazapine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00308	CcSEcCtD
Mirtazapine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00308	CcSEcCtD
Mirtazapine—DRD3—nervous system—amyotrophic lateral sclerosis	0.00162	0.00809	CbGeAlD
Mirtazapine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00304	CcSEcCtD
Mirtazapine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00303	CcSEcCtD
Mirtazapine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00158	0.003	CcSEcCtD
Mirtazapine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00158	0.003	CcSEcCtD
Mirtazapine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00298	CcSEcCtD
Mirtazapine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00156	0.00779	CbGeAlD
Mirtazapine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00295	CcSEcCtD
Mirtazapine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00289	CcSEcCtD
Mirtazapine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00288	CcSEcCtD
Mirtazapine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00286	CcSEcCtD
Mirtazapine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00286	CcSEcCtD
Mirtazapine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.0015	0.00752	CbGeAlD
Mirtazapine—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00285	CcSEcCtD
Mirtazapine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00281	CcSEcCtD
Mirtazapine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0028	CcSEcCtD
Mirtazapine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00278	CcSEcCtD
Mirtazapine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00277	CcSEcCtD
Mirtazapine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00275	CcSEcCtD
Mirtazapine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00145	0.00723	CbGeAlD
Mirtazapine—OPRK1—nervous system—amyotrophic lateral sclerosis	0.00144	0.00721	CbGeAlD
Mirtazapine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00274	CcSEcCtD
Mirtazapine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00143	0.00717	CbGeAlD
Mirtazapine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00268	CcSEcCtD
Mirtazapine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00264	CcSEcCtD
Mirtazapine—OPRK1—central nervous system—amyotrophic lateral sclerosis	0.00139	0.00694	CbGeAlD
Mirtazapine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00263	CcSEcCtD
Mirtazapine—HTR7—brainstem—amyotrophic lateral sclerosis	0.00138	0.00691	CbGeAlD
Mirtazapine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00262	CcSEcCtD
Mirtazapine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00262	CcSEcCtD
Mirtazapine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00138	0.00261	CcSEcCtD
Mirtazapine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00137	0.00685	CbGeAlD
Mirtazapine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0026	CcSEcCtD
Mirtazapine—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0026	CcSEcCtD
Mirtazapine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00258	CcSEcCtD
Mirtazapine—OPRK1—cerebellum—amyotrophic lateral sclerosis	0.00136	0.00678	CbGeAlD
Mirtazapine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00133	0.00666	CbGeAlD
Mirtazapine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00249	CcSEcCtD
Mirtazapine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00131	0.00653	CbGeAlD
Mirtazapine—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00246	CcSEcCtD
Mirtazapine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00244	CcSEcCtD
Mirtazapine—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00239	CcSEcCtD
Mirtazapine—Chills—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00236	CcSEcCtD
Mirtazapine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00235	CcSEcCtD
Mirtazapine—DRD3—brain—amyotrophic lateral sclerosis	0.00124	0.00618	CbGeAlD
Mirtazapine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00233	CcSEcCtD
Mirtazapine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00231	CcSEcCtD
Mirtazapine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00229	CcSEcCtD
Mirtazapine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.0012	0.00599	CbGeAlD
Mirtazapine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00226	CcSEcCtD
Mirtazapine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00225	CcSEcCtD
Mirtazapine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00225	CcSEcCtD
Mirtazapine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00223	CcSEcCtD
Mirtazapine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00222	CcSEcCtD
Mirtazapine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00215	CcSEcCtD
Mirtazapine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00213	CcSEcCtD
Mirtazapine—HTR3A—nervous system—amyotrophic lateral sclerosis	0.00112	0.00559	CbGeAlD
Mirtazapine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00212	CcSEcCtD
Mirtazapine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00211	CcSEcCtD
Mirtazapine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.00111	0.00552	CbGeAlD
Mirtazapine—OPRK1—brain—amyotrophic lateral sclerosis	0.0011	0.00551	CbGeAlD
Mirtazapine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00207	CcSEcCtD
Mirtazapine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00206	CcSEcCtD
Mirtazapine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00206	CcSEcCtD
Mirtazapine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00205	CcSEcCtD
Mirtazapine—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.00108	0.00539	CbGeAlD
Mirtazapine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00107	0.00534	CbGeAlD
Mirtazapine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00203	CcSEcCtD
Mirtazapine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00106	0.00202	CcSEcCtD
Mirtazapine—Cough—Riluzole—amyotrophic lateral sclerosis	0.00105	0.002	CcSEcCtD
Mirtazapine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00199	CcSEcCtD
Mirtazapine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00198	CcSEcCtD
Mirtazapine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00195	CcSEcCtD
Mirtazapine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00195	CcSEcCtD
Mirtazapine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00195	CcSEcCtD
Mirtazapine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00195	CcSEcCtD
Mirtazapine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00194	CcSEcCtD
Mirtazapine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00193	CcSEcCtD
Mirtazapine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00101	0.00506	CbGeAlD
Mirtazapine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.001	0.00191	CcSEcCtD
Mirtazapine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.001	0.005	CbGeAlD
Mirtazapine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000993	0.00189	CcSEcCtD
Mirtazapine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000985	0.00187	CcSEcCtD
Mirtazapine—Infection—Riluzole—amyotrophic lateral sclerosis	0.000979	0.00186	CcSEcCtD
Mirtazapine—Shock—Riluzole—amyotrophic lateral sclerosis	0.000969	0.00184	CcSEcCtD
Mirtazapine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000966	0.00184	CcSEcCtD
Mirtazapine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000964	0.00183	CcSEcCtD
Mirtazapine—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.000964	0.00482	CbGeAlD
Mirtazapine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000961	0.00183	CcSEcCtD
Mirtazapine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000957	0.00182	CcSEcCtD
Mirtazapine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000952	0.00181	CcSEcCtD
Mirtazapine—HTR2A—embryo—amyotrophic lateral sclerosis	0.000941	0.0047	CbGeAlD
Mirtazapine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000939	0.00178	CcSEcCtD
Mirtazapine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.000931	0.00465	CbGeAlD
Mirtazapine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00092	0.00175	CcSEcCtD
Mirtazapine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.0009	0.0045	CbGeAlD
Mirtazapine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.000899	0.00449	CbGeAlD
Mirtazapine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000897	0.00171	CcSEcCtD
Mirtazapine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.000897	0.00448	CbGeAlD
Mirtazapine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000891	0.00169	CcSEcCtD
Mirtazapine—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.000886	0.00443	CbGeAlD
Mirtazapine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000884	0.00168	CcSEcCtD
Mirtazapine—ADRB1—nervous system—amyotrophic lateral sclerosis	0.000884	0.00441	CbGeAlD
Mirtazapine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000878	0.00167	CcSEcCtD
Mirtazapine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.000877	0.00438	CbGeAlD
Mirtazapine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000876	0.00166	CcSEcCtD
Mirtazapine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000867	0.00165	CcSEcCtD
Mirtazapine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.000867	0.00433	CbGeAlD
Mirtazapine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.000862	0.00431	CbGeAlD
Mirtazapine—HTR7—spinal cord—amyotrophic lateral sclerosis	0.00086	0.00429	CbGeAlD
Mirtazapine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000856	0.00163	CcSEcCtD
Mirtazapine—HTR3A—brain—amyotrophic lateral sclerosis	0.000856	0.00428	CbGeAlD
Mirtazapine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.000854	0.00426	CbGeAlD
Mirtazapine—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.000851	0.00425	CbGeAlD
Mirtazapine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00085	0.00162	CcSEcCtD
Mirtazapine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000849	0.00161	CcSEcCtD
Mirtazapine—HTR2B—nervous system—amyotrophic lateral sclerosis	0.000846	0.00423	CbGeAlD
Mirtazapine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000842	0.0016	CcSEcCtD
Mirtazapine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000842	0.0016	CcSEcCtD
Mirtazapine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.000822	0.00411	CbGeAlD
Mirtazapine—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.000814	0.00407	CbGeAlD
Mirtazapine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000812	0.00154	CcSEcCtD
Mirtazapine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000805	0.00153	CcSEcCtD
Mirtazapine—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.00079	0.00395	CbGeAlD
Mirtazapine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000785	0.00392	CbGeAlD
Mirtazapine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000783	0.00149	CcSEcCtD
Mirtazapine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000779	0.00148	CcSEcCtD
Mirtazapine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000779	0.00148	CcSEcCtD
Mirtazapine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.000758	0.00379	CbGeAlD
Mirtazapine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.000751	0.00375	CbGeAlD
Mirtazapine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00073	0.00365	CbGeAlD
Mirtazapine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000726	0.00138	CcSEcCtD
Mirtazapine—HTR7—nervous system—amyotrophic lateral sclerosis	0.000724	0.00362	CbGeAlD
Mirtazapine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.000723	0.00362	CbGeAlD
Mirtazapine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.000713	0.00356	CbGeAlD
Mirtazapine—SLC6A3—brain—amyotrophic lateral sclerosis	0.000712	0.00356	CbGeAlD
Mirtazapine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.000707	0.00353	CbGeAlD
Mirtazapine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000707	0.00134	CcSEcCtD
Mirtazapine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.000699	0.00349	CbGeAlD
Mirtazapine—HTR7—central nervous system—amyotrophic lateral sclerosis	0.000697	0.00348	CbGeAlD
Mirtazapine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000697	0.00132	CcSEcCtD
Mirtazapine—HTR2C—brain—amyotrophic lateral sclerosis	0.000688	0.00344	CbGeAlD
Mirtazapine—DRD2—nervous system—amyotrophic lateral sclerosis	0.000685	0.00342	CbGeAlD
Mirtazapine—HTR7—cerebellum—amyotrophic lateral sclerosis	0.000682	0.00341	CbGeAlD
Mirtazapine—ADRB1—brain—amyotrophic lateral sclerosis	0.000675	0.00337	CbGeAlD
Mirtazapine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000674	0.00128	CcSEcCtD
Mirtazapine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.000673	0.00336	CbGeAlD
Mirtazapine—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.000666	0.00333	CbGeAlD
Mirtazapine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.000659	0.00329	CbGeAlD
Mirtazapine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.000657	0.00328	CbGeAlD
Mirtazapine—SLC6A4—brain—amyotrophic lateral sclerosis	0.000652	0.00326	CbGeAlD
Mirtazapine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000651	0.00124	CcSEcCtD
Mirtazapine—HTR2B—brain—amyotrophic lateral sclerosis	0.000646	0.00323	CbGeAlD
Mirtazapine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.000644	0.00322	CbGeAlD
Mirtazapine—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.000641	0.0032	CbGeAlD
Mirtazapine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00063	0.00315	CbGeAlD
Mirtazapine—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.000626	0.00313	CbGeAlD
Mirtazapine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000626	0.00119	CcSEcCtD
Mirtazapine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000621	0.00118	CcSEcCtD
Mirtazapine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00062	0.00118	CcSEcCtD
Mirtazapine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000617	0.00117	CcSEcCtD
Mirtazapine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.000601	0.003	CbGeAlD
Mirtazapine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000585	0.00111	CcSEcCtD
Mirtazapine—HTR1A—brain—amyotrophic lateral sclerosis	0.000579	0.00289	CbGeAlD
Mirtazapine—SLC6A2—brain—amyotrophic lateral sclerosis	0.000574	0.00287	CbGeAlD
Mirtazapine—HTR7—brain—amyotrophic lateral sclerosis	0.000554	0.00277	CbGeAlD
Mirtazapine—HRH1—nervous system—amyotrophic lateral sclerosis	0.000541	0.0027	CbGeAlD
Mirtazapine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.000536	0.00268	CbGeAlD
Mirtazapine—ADRA1A—brain—amyotrophic lateral sclerosis	0.000534	0.00267	CbGeAlD
Mirtazapine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.000531	0.00265	CbGeAlD
Mirtazapine—DRD2—brain—amyotrophic lateral sclerosis	0.000523	0.00262	CbGeAlD
Mirtazapine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.000521	0.0026	CbGeAlD
Mirtazapine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.000511	0.00256	CbGeAlD
Mirtazapine—ADRA2C—brain—amyotrophic lateral sclerosis	0.000509	0.00254	CbGeAlD
Mirtazapine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.0005	0.0025	CbGeAlD
Mirtazapine—CYP2C8—brain—amyotrophic lateral sclerosis	0.000472	0.00236	CbGeAlD
Mirtazapine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000452	0.00226	CbGeAlD
Mirtazapine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000435	0.00217	CbGeAlD
Mirtazapine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000425	0.00212	CbGeAlD
Mirtazapine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000418	0.00209	CbGeAlD
Mirtazapine—HRH1—brain—amyotrophic lateral sclerosis	0.000413	0.00207	CbGeAlD
Mirtazapine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000411	0.00206	CbGeAlD
Mirtazapine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000406	0.00203	CbGeAlD
Mirtazapine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000403	0.00201	CbGeAlD
Mirtazapine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000396	0.00198	CbGeAlD
Mirtazapine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000387	0.00193	CbGeAlD
Mirtazapine—HTR2A—brain—amyotrophic lateral sclerosis	0.000345	0.00172	CbGeAlD
Mirtazapine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000314	0.00157	CbGeAlD
Mirtazapine—DRD4—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.66e-05	0.000307	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.65e-05	0.000305	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.64e-05	0.000305	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	2.64e-05	0.000304	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	2.61e-05	0.000301	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.59e-05	0.000299	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	2.59e-05	0.000298	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.54e-05	0.000293	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.54e-05	0.000293	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	2.5e-05	0.000289	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	2.5e-05	0.000289	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	2.48e-05	0.000286	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.48e-05	0.000286	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.48e-05	0.000286	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.47e-05	0.000285	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.46e-05	0.000284	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.42e-05	0.00028	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.42e-05	0.000279	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.42e-05	0.000279	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.41e-05	0.000278	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.4e-05	0.000277	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.4e-05	0.000277	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.38e-05	0.000274	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.37e-05	0.000274	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.36e-05	0.000273	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.36e-05	0.000272	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.36e-05	0.000272	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.35e-05	0.000272	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	2.34e-05	0.00027	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.31e-05	0.000266	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.31e-05	0.000266	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.3e-05	0.000265	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.29e-05	0.000265	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.28e-05	0.000264	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.28e-05	0.000263	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.27e-05	0.000262	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.26e-05	0.000261	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.26e-05	0.000261	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.26e-05	0.000261	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.24e-05	0.000258	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.23e-05	0.000257	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.21e-05	0.000255	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	2.2e-05	0.000254	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.18e-05	0.000251	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.17e-05	0.000251	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.16e-05	0.000249	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.15e-05	0.000248	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.15e-05	0.000248	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	2.15e-05	0.000248	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.14e-05	0.000247	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.14e-05	0.000247	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.14e-05	0.000247	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.14e-05	0.000247	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	2.12e-05	0.000245	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.11e-05	0.000243	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.1e-05	0.000242	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	2.1e-05	0.000242	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	2.09e-05	0.000241	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.09e-05	0.000241	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.06e-05	0.000238	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.06e-05	0.000237	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	2.05e-05	0.000236	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.04e-05	0.000236	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.04e-05	0.000235	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	2.02e-05	0.000234	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.02e-05	0.000233	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.01e-05	0.000232	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.99e-05	0.00023	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.99e-05	0.00023	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.99e-05	0.000229	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.98e-05	0.000228	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.95e-05	0.000225	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	1.95e-05	0.000225	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.93e-05	0.000223	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.92e-05	0.000222	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.92e-05	0.000221	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.9e-05	0.000219	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.9e-05	0.000219	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.89e-05	0.000218	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.87e-05	0.000216	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.87e-05	0.000215	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.86e-05	0.000215	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.86e-05	0.000214	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.84e-05	0.000213	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.84e-05	0.000212	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.83e-05	0.000211	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.81e-05	0.000209	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.81e-05	0.000209	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.81e-05	0.000208	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.8e-05	0.000208	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.78e-05	0.000205	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.78e-05	0.000205	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.77e-05	0.000205	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.76e-05	0.000203	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.76e-05	0.000203	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.75e-05	0.000202	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.74e-05	0.000201	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.74e-05	0.000201	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.73e-05	0.0002	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.71e-05	0.000197	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.71e-05	0.000197	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.7e-05	0.000196	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.7e-05	0.000196	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.69e-05	0.000196	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.68e-05	0.000194	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.68e-05	0.000194	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.66e-05	0.000191	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	0.00019	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.64e-05	0.000189	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.62e-05	0.000187	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.6e-05	0.000185	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.59e-05	0.000183	CbGpPWpGaD
Mirtazapine—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	1.59e-05	0.000183	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	1.58e-05	0.000182	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.57e-05	0.000181	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.56e-05	0.00018	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	0.00018	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.55e-05	0.000179	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.54e-05	0.000178	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.53e-05	0.000177	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.52e-05	0.000176	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.52e-05	0.000175	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.52e-05	0.000175	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.5e-05	0.000173	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.49e-05	0.000172	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.46e-05	0.000169	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.46e-05	0.000168	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.46e-05	0.000168	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.45e-05	0.000168	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.45e-05	0.000167	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000165	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000165	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.43e-05	0.000164	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.42e-05	0.000163	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.4e-05	0.000162	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.39e-05	0.000161	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.39e-05	0.00016	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	1.39e-05	0.00016	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.36e-05	0.000157	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.36e-05	0.000156	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.35e-05	0.000155	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	1.34e-05	0.000155	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.32e-05	0.000152	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	1.3e-05	0.00015	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.29e-05	0.000149	CbGpPWpGaD
Mirtazapine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	1.29e-05	0.000149	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.29e-05	0.000148	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	1.28e-05	0.000148	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.27e-05	0.000147	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.27e-05	0.000146	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.26e-05	0.000146	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.24e-05	0.000143	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.24e-05	0.000143	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.2e-05	0.000138	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.19e-05	0.000137	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.18e-05	0.000136	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.18e-05	0.000136	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.18e-05	0.000136	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.17e-05	0.000135	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.15e-05	0.000133	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.15e-05	0.000133	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	1.15e-05	0.000133	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.13e-05	0.00013	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.12e-05	0.00013	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.12e-05	0.000129	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.12e-05	0.000129	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.11e-05	0.000128	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.1e-05	0.000127	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.09e-05	0.000126	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.09e-05	0.000126	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.09e-05	0.000126	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.08e-05	0.000125	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	1.07e-05	0.000124	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.07e-05	0.000123	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.06e-05	0.000122	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	1.02e-05	0.000117	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000117	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.01e-05	0.000117	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.01e-05	0.000116	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.01e-05	0.000116	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.95e-06	0.000115	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.93e-06	0.000115	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.89e-06	0.000114	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.73e-06	0.000112	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.71e-06	0.000112	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.53e-06	0.00011	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.51e-06	0.00011	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	9.4e-06	0.000108	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.36e-06	0.000108	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.07e-06	0.000105	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.07e-06	0.000105	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.87e-06	0.000102	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.86e-06	0.000102	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.78e-06	0.000101	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.67e-06	0.0001	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.63e-06	9.95e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.6e-06	9.92e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.57e-06	9.88e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	8.44e-06	9.74e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	8.39e-06	9.68e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.38e-06	9.67e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	8.35e-06	9.63e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	8.28e-06	9.55e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.2e-06	9.45e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.15e-06	9.41e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.93e-06	9.15e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.69e-06	8.88e-05	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.62e-06	8.79e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.61e-06	8.78e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.53e-06	8.68e-05	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.5e-06	8.66e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.49e-06	8.64e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.48e-06	8.62e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.36e-06	8.49e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.34e-06	8.46e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.32e-06	8.45e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.22e-06	8.33e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.2e-06	8.3e-05	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.18e-06	8.29e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.12e-06	8.22e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.08e-06	8.17e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	7.07e-06	8.16e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	7.06e-06	8.15e-05	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.97e-06	8.04e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.93e-06	8e-05	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.86e-06	7.91e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.82e-06	7.86e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.64e-06	7.66e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.46e-06	7.45e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.44e-06	7.43e-05	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.38e-06	7.36e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.36e-06	7.33e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.34e-06	7.32e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.23e-06	7.18e-05	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.81e-06	6.71e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.78e-06	6.67e-05	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.72e-06	6.6e-05	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.69e-06	6.56e-05	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.67e-06	6.54e-05	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.56e-06	6.41e-05	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.53e-06	6.38e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	5.46e-06	6.3e-05	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.38e-06	6.21e-05	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.88e-06	5.63e-05	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.85e-06	5.59e-05	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.8e-06	5.54e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.79e-06	5.53e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.7e-06	5.43e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.37e-06	5.04e-05	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.74e-06	4.32e-05	CbGpPWpGaD
